Connection between COVID-19 and pulmonary vascular disease

25 March 2021

A PVRI 2021 Digital webinar

Presentations 

  • SARS-1, MERS, SARS-2 and more: are coronavirus infections an ubiquitous part of our lives? Albert Osterhaus
  •  Endothelitis and aberrant angiogenesis – mechanisms of COVID-19 induced vascular injury, Danny Jonigk
  • Venous thromboembolism in COVID-19: Prevalence and clinical picture, Stavros Konstantinides
  • ACE-II receptors – Modulation of PVD in COVID-19? Anna Hemnes
  • Tricuspid regurgitation, as proxy for acute pulmonary hypertension, and its association with short-term outcome in severe Covid-19, Claes Frostell 
  • Venous and arterial thromboembolism in COVID-19: a systematic review with meta-analysis, Vicky Mai

Speakers & moderators

Albert Osterhaus, Erasmus University Rotterdam, Netherlands
Danny Jonigk, University Hospital RWTH Aachen, Germany
Stavros Konstantinides, Democritus University of Thrace, Greece
Anna Hemnes, Vanderbilt University, USA
Claes Frostell, Karolinska Institute, Sweden
Vicky Mai, University of Ottawa, Canada
Share:
Additional comments are available to members. Login or register to become a member today